Biotech-IgG AB is a biotechnology company based in Lund, Sweden. The company specializes in the development and production of therapeutic antibodies and other biologics. Biotech-IgG AB focuses on innovative solutions in the field of immunotherapy, aiming to address various medical conditions through advanced biotechnological methods.
The company engages in research and development activities that encompass the entire lifecycle of antibody production, from initial discovery through to clinical development. Biotech-IgG AB collaborates with academic institutions and other organizations to enhance its research capabilities and expand its product offerings. The firm is part of a growing biotechnology sector in Sweden, which is known for its strong emphasis on life sciences and innovation.